Scholarlink

<p>Postmenopausal osteoporosis (PMOP), a prevalent skeletal disorder among postmenopausal women, is hallmarked by heightened fracture susceptibility. Estrogen deficiency in this condition impairs the endogenous antioxidant defense system, triggering iron overload within the bone marrow mesenchymal stem cell (BMSC) niche and disrupting bone metabolic homeostasis. Guided by this mechanistic framework, we focused on ginsenoside Rc (Rc), a bioactive phytochemical endowed with capacities to enhance antioxidant defenses and potential iron-regulating activities. We engineered DT-NPNs/Rc via a pathogen-mimetic strategy, entailing hybridization of bacterial outer membrane vesicles (OMVs) with BMSC-derived membranes for encapsulation of Rc. These nanoconstructs exploit the bone marrow-homing properties of circulating neutrophils for hitchhiking, followed by specific internalization by BMSCs to achieve targeted Rc delivery. Functional assessments revealed that DT-NPNs/Rc mitigates lipid peroxidation through SIRT1/p53 axis, thereby restoring the osteogenic differentiation capacity of BMSCs under iron overload. Notably, in vivo studies confirmed that DT-NPNs/Rc effectively attenuates ovariectomy (OVX)-induced bone loss. Collectively, by overcoming the limitations of conventional delivery systems in targeting, DT-NPNs/Rc offered an innovative, highly efficient, and clinically translatable platform for PMOP treatment.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Biomimetic hybrid nanocarriers hitchhike neutrophils for targeted ginsenoside Rc delivery to BMSCs: ameliorating postmenopausal osteoporosis via iron homeostasis regulation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月3日

查看全文
  • Yi He,
  • Depeng Fang,
  • Binjie Huang,
  • Xiang Chen,
  • Zhengmin Zhang,
  • Zihan Wang,
  • Qing Jiang,
  • Baosheng Guo,
  • Weidong Xiao

摘要

Postmenopausal osteoporosis (PMOP), a prevalent skeletal disorder among postmenopausal women, is hallmarked by heightened fracture susceptibility. Estrogen deficiency in this condition impairs the endogenous antioxidant defense system, triggering iron overload within the bone marrow mesenchymal stem cell (BMSC) niche and disrupting bone metabolic homeostasis. Guided by this mechanistic framework, we focused on ginsenoside Rc (Rc), a bioactive phytochemical endowed with capacities to enhance antioxidant defenses and potential iron-regulating activities. We engineered DT-NPNs/Rc via a pathogen-mimetic strategy, entailing hybridization of bacterial outer membrane vesicles (OMVs) with BMSC-derived membranes for encapsulation of Rc. These nanoconstructs exploit the bone marrow-homing properties of circulating neutrophils for hitchhiking, followed by specific internalization by BMSCs to achieve targeted Rc delivery. Functional assessments revealed that DT-NPNs/Rc mitigates lipid peroxidation through SIRT1/p53 axis, thereby restoring the osteogenic differentiation capacity of BMSCs under iron overload. Notably, in vivo studies confirmed that DT-NPNs/Rc effectively attenuates ovariectomy (OVX)-induced bone loss. Collectively, by overcoming the limitations of conventional delivery systems in targeting, DT-NPNs/Rc offered an innovative, highly efficient, and clinically translatable platform for PMOP treatment.

Graphical Abstract